Seed Investment

BioLinker is raising a seed round to scale its synthetic biology platform and accelerate the commercialization of disruptive biotech solutions like InvitroLinker. We are currently part of Next Sequence, a prestigious accelerator based in Silicon Valley focused on empowering high-impact startups at the intersection of biotechnology and artificial intelligence.

This round will support the expansion of our production capacity, regulatory validation, and market entry for high-value applications in animal health, diagnostics, and industrial biotech. Join us for our final pitch at the Next Sequence Demo Day, where we’ll share exclusive details on our technology roadmap, strategic partnerships, and investment opportunities.

We are building Latin America’s largest synthetic biology company—and this is your chance to be part of that journey.